Sponsored Content
Development and GMP Manufacturing of Biopharmaceuticals
Kai Pohlmeyer
August 1, 2011
2 Min Read
Richter-Helm BioTec is a dynamic and expanding biotechnology company located in Hamburg, Germany. Being one of the first biopharmaceutical enterprises in Europe, Richter-Helm has more than 20 years of experience in the development and GMP-compliant production of recombinant proteins, plasmid DNA, and microbial vaccines. With more than 120 employees Richter-Helm offers customized state-of-the-art solutions for all steps in biopharmaceutical projects through contract development and manufacturing services in GMP facilities for microbial production (fermentation scale up to 1,500 L). Beside our strong expertise in Escherichia coli, Richter-Helm successfully produces proteins in yeast (e.g., Pichia pastoris). Thus Richter-Helm is the ideal partner for biopharmaceuticals development by offering material from preclinical and clinical trials to market supply at a large scale. In addition Richter-Helm is the platform of Gedeon-Richter and Helm AG for worldwide licensing options as well as partnerships for codevelopment and marketing of biopharmaceutical development projects.
Products and Services
The teams at Richter-Helm have excellent expertise in development and manufacturing of biopharmaceuticals. This knowledge, combined with highest quality standards according to current regulatory requirements, is a prerequisite for reliable and successful collaborations. Richter-Helm offers its customers a full range of biopharmaceutical services
Production of Recombinant Proteins
development of production strains (e.g., E. coli and Pichia)
optimization of expression in different systems
establishment of MCB/WCB, development of fermentation (10–1,500 L) and downstream processes
development and validation of analytical methods including bioassays
clinical phase 1–3 and commercial GMP manufacturing
process validation, in-house QC testing, and release, and stability studies according to ICH.
Production of Plasmid DNA
development of production strains and establishment of MCB/WCB
development of fermentation (10–1,500 L) and downstream processes
development of analytical methods
GMP manufacturing for clinical phase 1–3 and commercial manufacturing
in-house QC testing and release
Production of Vaccines: Richter-Helm has long-lasting experience in development and manufacturing of microbial vaccines.
Business Development: Richter-Helm offers in- and out-licensing as well as partnerships for codevelopment.
Richter-Helm BioTec is evaluating new development projects to enlarge its own development pipeline and is offering license opportunities for co-development and marketing of biopharmaceutical products.
About the Author
Author Details
Kai Pohlmeyer, PhD, is head of business development at Richter-Helm BioTec GmbH & Co. KG, Nordkanalstrasse 28, 20097 Hamburg, Germany; 49-40-2375-2430; [email protected]; www.richter-helm.eu
You May Also Like
Sponsored Content
Jun 5 - Jun 6, 2024
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More
